Cite
HARVARD Citation
Dunkel, Y. et al. (2016). Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers. FASEB journal. 30 (11), pp. 3702-3713. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dunkel, Y. et al. (2016). Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers. FASEB journal. 30 (11), pp. 3702-3713. [Online].